Ebola vaccine induces T cell cross-reactivity against Bundibugyo virus in humans
The current Bundibugyo Ebola virus (BDBV) outbreak in the Democratic Republic of the Congo is the second largest Ebola outbreak worldwide, with over 6,000 confirmed cases and a 48% fatality rate. There ...
14 Oct 22:20 · Medical Xpress
Ebola vaccine triggers cross reactive T cells against Bundibugyo ebolavirus
The ongoing Bundibugyo ebolavirus (BDBV) outbreak in the Democratic Republic of the Congo is the second-largest Ebolavirus outbreak globally, with more than 6,000 confirmed cases and a mortality rate of 48 percent.
14 Oct 19:22 · News-Medical
last updated on 14 Oct 23:41